More data coming in about vaccine effectiveness against Omicron
Data is still coming in on vaccines versus the Omicron variant.
pfizer
Pfizer shares data from experimental COVID-19 treatment with the FDA
Final data on Pfizer’s experimental treatment for COVID-19 has now been shared with the FDA. It’s part of the company’s application to authorize the pill for emergency use.
BACK ON THE RISE: State health officials urge South Carolinians to exercise caution over Thanksgiving break as COVID cases increase
“I don’t want to hit the panic button but we are strongly encouraging South Carolinians to continue the safety protocols that helped us drive the numbers down from that high point back in September,” Traxler said.
Pfizer asks US officials to OK promising COVID-19 pill
Pfizer is submitting its experimental pill for COVID-19 for U.S. authorization, setting the stage for a likely launch of the promising therapy in coming weeks.
TOO EARLY TO DITCH THE MASKS? DHEC official urges people to follow health guidelines
“We are well versed in hurricane season here. I don’t know if we are in the eye of the storm or if the storm has fully passed,” Dr. Knoche said.
SC health experts recommend Pfizer vaccine for children ages 5 to 11 after CDC approval
Pediatricians urge parents to consult medical professionals if they have questions instead of the internet or social media.
US panel urges kids 5-11 get COVID shots, final OK due soon
By Lauran Neergaard and Mike Stobbe
An influential advisory panel on Tuesday recommended kid-size doses of Pfizer’s COVID-19 vaccine for children ages 5 to 11, putting the U.S. on the brink of a major expansion of vaccinations. A final decision was expected within hours.
CDC vaccine advisors set to vote on Pfizer’s COVID-19 vaccine for kids ages 5-11
The CDC’s vaccine advisors are set to vote on Pfizer’s COVID-19 vaccine for children ages 5-11 Tuesday.
FDA paves way for Pfizer COVID-19 vaccinations in young kids
By Matthew Perrone and Lauran Neergaard
The Food and Drug Administration on Friday paved the way for children ages 5 to 11 to get Pfizer’s COVID-19 vaccine. The FDA cleared kid-size doses — just a third of the amount given to teens and adults — for emergency use, and up to 28 million more American children could be eligible for vaccinations as early as next week.
Survey finds most parents are hesitant to vaccinate their young kids against COVID-19
Health officials are closing in on a decision about Pfizer’s COVID-19 vaccine for kids ages 5-11, but a new survey shows significant hesitancy among parents to get young children vaccinated.
